Purchases and Sales Made in Q4 2022 in Ascendis Pharma A/S (ASND)
This table provides information about the institutional ownership of Ascendis Pharma A/S (ASND) during Q4 2022. The information is specifically focused on institutions that hold shares of Ascendis Pharma A/S.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 13, 2023
Q4 2022
|
Barclays PLC
London, X0 |
SELL
|
- |
-68.1K- 54.57% |
$6.77M - $8.99M
|
56.7K
$7.73M
|
|
|
Feb 14, 2023
Q4 2022
|
Putnam Investments LLC
Boston, MA |
SELL
|
- |
-81.7K- 10.36% |
$8.12M - $10.8M
|
706K
$96.3M
|
|
|
Feb 14, 2023
Q4 2022
|
Morgan Stanley
New York, NY |
SELL
|
- |
-88.5K- 51.62% |
$8.8M - $11.7M
|
82.9K
$11.3M
|
|
|
Feb 14, 2023
Q4 2022
|
Deep Track Capital, LP
Greenwich, CT |
SELL
|
- |
-100K- 12.5% |
$9.94M - $13.2M
|
700K
$95.5M
|
|
|
Feb 14, 2023
Q4 2022
|
Woodline Partners LP
San Francisco, CA |
SELL
|
- |
-116K- 55.01% |
$11.6M - $15.3M
|
95.1K
$13M
|
|
|
Feb 14, 2023
Q4 2022
|
Paradigm Biocapital Advisors LP
New York, NY |
SELL
|
- |
-145K- 29.06% |
$14.4M - $19.1M
|
353K
$48.1M
|
|
|
Feb 14, 2023
Q4 2022
|
Alliancebernstein L.P.
New York, NY |
SELL
|
- |
-150K- 23.43% |
$14.9M - $19.8M
|
490K
$66.8M
|
|
|
Feb 14, 2023
Q4 2022
|
Marshall Wace, LLP
London, X0 |
SELL
|
- |
-155K- 60.05% |
$15.5M - $20.5M
|
103K
$14.1M
|
|
|
Feb 14, 2023
Q4 2022
|
Price T Rowe Associates Inc
Baltimore, MD |
SELL
|
- |
-165K- 4.26% |
$16.4M - $21.8M
|
3.71M
$506M
|
|
|
Feb 14, 2023
Q4 2022
|
Janus Henderson Group PLC
London, X0 |
SELL
|
- |
-193K- 5.03% |
$19.2M - $25.4M
|
3.64M
$497M
|
|
|
Feb 13, 2023
Q4 2022
|
Brown Advisory Inc
|
SELL
|
- |
-198K- 30.99% |
$19.7M - $26.1M
|
440K
$60M
|
|
|
Feb 10, 2023
Q4 2022
|
Artisan Partners Limited Partnership
Milwaukee, WI |
SELL
|
- |
-229K- 3.2% |
$22.8M - $30.2M
|
6.92M
$944M
|
|
|
Feb 14, 2023
Q4 2022
|
Spyglass Capital Management LLC
San Francisco, CA |
SELL
|
- |
-235K- 24.79% |
$23.4M - $31.1M
|
714K
$97.4M
|
|
|
Feb 13, 2023
Q4 2022
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-339K- 11.86% |
$33.7M - $44.7M
|
2.52M
$344M
|
|
|
May 14, 2024
Q4 2022
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-339K- 11.86% |
$33.7M - $44.7M
|
2.52M
$344M
|
|
|
Feb 13, 2023
Q4 2022
|
Eventide Asset Management, LLC
Boston, MA |
SELL
|
- |
-416K- 34.72% |
$41.4M - $54.9M
|
783K
$107M
|
|
|
Feb 14, 2023
Q4 2022
|
Ra Capital Management, L.P.
Boston, MA |
SELL
|
- |
-611K- 8.07% |
$60.7M - $80.6M
|
6.96M
$949M
|
|
|
Feb 13, 2023
Q4 2022
|
Wellington Management Group LLP
Boston, MA |
SELL
|
- |
-619K- 16.85% |
$61.5M - $81.6M
|
3.05M
$416M
|